Intravesical cidofovir to treat BK virus-associated hemorrhagic cystitis in children after hematopoietic stem cell transplantation

Pediatric Transplantation

Volumn 19, Issue 4, 2015, Pages E111-E114

  Rascon, Jelena ^a   Verkauskas, Gilvydas ^a   Pasauliene, Ramune ^a   Zubka, Vytautas ^a   Bilius, Vytautas ^a   Rageliene, Lina ^a  

^a VILNIUS UNIVERSITY   (Lithuania)

Author keywords

BK virus; cidofovir; hematopoietic stem cell transplantation; hemorrhagic cystitis; intravesical instillation

Indexed keywords

CIDOFOVIR; ANTIVIRUS AGENT; CYTOSINE; FORMALDEHYDE; PHOSPHONIC ACID DERIVATIVE;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ANTIVIRAL THERAPY; ARTICLE; BK VIRUS INFECTION; BLADDER CATHETERIZATION; CASE REPORT; CHILD; CHILDHOOD MORTALITY; CYSTOSTOMY; DRUG RESPONSE; FEMALE; FOLEY BALLOON CATHETER; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATURIA; HEMORRHAGIC CYSTITIS; HUMAN; INTERMITTENT CATHETERIZATION; LOW DRUG DOSE; MALE; NEPHROSTOMY; QUALITY OF LIFE; RESPIRATORY SYNCYTIAL VIRUS INFECTION; URETER CATHETERIZATION; URETER DILATATION; URETHRAL CATHETERIZATION; URINE LEVEL; VIREMIA; VIRUS LOAD; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; BK VIRUS; CYSTITIS; GRAFT VERSUS HOST REACTION; HEMORRHAGE; IMMUNE SYSTEM; IMMUNOLOGY; INTRAVESICAL DRUG ADMINISTRATION; POLYMERASE CHAIN REACTION; POLYOMAVIRUS INFECTIONS; PROCEDURES; TIME FACTOR;

ADMINISTRATION, INTRAVESICAL; ADOLESCENT; ANTIVIRAL AGENTS; BK VIRUS; CHILD; CYSTITIS; CYTOSINE; FEMALE; FORMALDEHYDE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGE; HUMANS; IMMUNE SYSTEM; MALE; ORGANOPHOSPHONATES; POLYMERASE CHAIN REACTION; POLYOMAVIRUS INFECTIONS; TIME FACTORS;

EID: 84929048220     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/petr.12477     Document Type: Article

References (16)

1. Harkensee C, Vasdev N, Gennery AR, Willetts IE, Taylor C,. Prevention and management of BK-virus associated haemorrhagic cystitis in children following haematopoietic stem cell transplantation- A systematic review and evidence-based guidance for clinical management. Br J Haematol 2008: 142: 717-731.
2. Mackey MC,. Intravesicular cidofovir for the treatment of polyomavirus-associated hemorrhagic cystitis. Ann Pharmacother 2012: 46: 442-446.
3. Walden O, Hartel C, Doehn C, Jocham D,. Intravesical cidofovir-instillation therapy for polyomavirus-associated hemorrhagic cystitis after bone marrow transplantation. Urologe A 2007: 46: 535-537.
4. Koskenvuo M, Dumoulin A, Lautenschlager I, et al. BK polyomavirus-associated hemorrhagic cystitis among pediatric allogeneic bone marrow transplant recipients: Treatment response and evidence for nosocomial transmission. J Clin Virol 2013: 56: 77-81.
5. Hingorani S,. Kidney and bladder complications of hematopoietic cell transplantation. In:, Appelbaum FR, Forman SJ, Negrin RS, Blume KG, eds. Thomas' Hematopoietic Cell Transplantation, 4th edn. Chichester, West Sussex, UK: Wiley-Blackwell Publishing, 2009: pp 1473-1486.
6. Gaziev J, Paba P, Miano R, et al. Late-onset hemorrhagic cystitis in children after hematopoietic stem cell transplantation for thalassemia and sickle cell anemia: A prospective evaluation of polyoma (BK) virus infection and treatment with cidofovir. Biol Blood Marrow Transplant 2010: 16: 662-671.
7. Haines HL, Laskin BL, Goebel J, et al. Blood, and not urine, BK viral load predicts renal outcome in children with hemorrhagic cystitis following hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2011: 17: 1512-1519.
8. Cesaro S, Hirsch HH, Faraci M, et al. Cidofovir for BK virus-associated hemorrhagic cystitis: A retrospective study. Clin Infect Dis 2009: 49: 233-240.
9. Cesaro S, Pillon M, Tridello G, et al. Relationship between clinical and BK virological response in patients with late hemorrhagic cystitis treated with cidofovir: A retrospective study from the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2013: 48: 809-813.
10. Faraci M, Cuzzubbo D, Lanino E, et al. Low dosage cidofovir without probenecid as treatment for BK virus hamorrhagic cystitis after hemopoietic stem cell transplant. Pediatr Infect Dis J 2009: 28: 55-57.
11. Silva Lde P, Patah PA, Saliba RM, et al. Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type. Haematologica 2010: 95: 1183-1190.
12. Childs R, Sanchez C, Engler H, et al. High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine. Bone Marrow Transplant 1998: 22: 889-893.
13. Agha I, Brennan DC,. BK virus and immunosuppressive agents. Adv Exp Med Biol 2006: 577: 174-184.
14. Schachtner T, Muller K, Stein M, et al. BK virus-specific immunity kinetics: A predictor of recovery from polyomavirus BK-associated nephropathy. Am J Transplant 2011: 11: 2443-2452.
15. Laskin BL, Denburg M, Furth S, et al. BK viremia precedes hemorrhagic cystitis in children undergoing allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2013: 19: 1175-1182.
16. Oshrine B, Bunin N, Li Y, Furth S, Laskin BL,. Kidney and bladder outcomes in children with hemorrhagic cystitis and BK virus infection after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2013: 19: 1702-1707.